Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Measles-containing vaccines and febrile seizures in children age 4 to 6 years.

Klein NP, Lewis E, Baxter R, Weintraub E, Glanz J, Naleway A, Jackson LA, Nordin J, Lieu T, Belongia EA, Fireman B.

Pediatrics. 2012 May;129(5):809-14. doi: 10.1542/peds.2011-3198. Epub 2012 Apr 2.

PMID:
22473362
[PubMed - indexed for MEDLINE]
Free Article
2.

Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, Broder KR, Temte JL, Snider DE, Seward JF; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 May 7;59(RR-3):1-12.

PMID:
20448530
[PubMed - indexed for MEDLINE]
Free Article
3.

Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.

Committee on Infectious Diseases.

Pediatrics. 2011 Sep;128(3):630-2. doi: 10.1542/peds.2011-1968. Epub 2011 Aug 28.

PMID:
21873692
[PubMed - indexed for MEDLINE]
Free Article
4.

Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.

Gillet Y, Steri GC, Behre U, Arsène JP, Lanse X, Helm K, Esposito S, Meister N, Desole MG, Douha M, Willems P.

Vaccine. 2009 Jan 14;27(3):446-53. doi: 10.1016/j.vaccine.2008.10.064. Epub 2008 Nov 11.

PMID:
19007835
[PubMed - indexed for MEDLINE]
5.

Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

Knuf M, Habermehl P, Zepp F, Mannhardt W, Kuttnig M, Muttonen P, Prieler A, Maurer H, Bisanz H, Tornieporth N, Descamps D, Willems P.

Pediatr Infect Dis J. 2006 Jan;25(1):12-8.

PMID:
16395096
[PubMed - indexed for MEDLINE]
6.

Febrile seizures and measles-mumps-rubella-varicella (MMRV) vaccine: what do primary care physicians think?

O'Leary ST, Suh CA, Marin M; Vaccine Policy Collaborative Initiative.

Vaccine. 2012 Nov 6;30(48):6731-3. doi: 10.1016/j.vaccine.2012.08.075. Epub 2012 Sep 10.

PMID:
22975026
[PubMed - indexed for MEDLINE]
7.

Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.

Vesikari T, Baer M, Willems P.

Pediatr Infect Dis J. 2007 Feb;26(2):153-8.

PMID:
17259879
[PubMed - indexed for MEDLINE]
8.

Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.

Jacobsen SJ, Ackerson BK, Sy LS, Tran TN, Jones TL, Yao JF, Xie F, Cheetham TC, Saddier P.

Vaccine. 2009 Jul 23;27(34):4656-61. doi: 10.1016/j.vaccine.2009.05.056. Epub 2009 Jun 9.

PMID:
19520201
[PubMed - indexed for MEDLINE]
9.

Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.

Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.

Pediatr Infect Dis J. 2008 Aug;27(8):724-30. doi: 10.1097/INF.0b013e318170bb22. Erratum in: Pediatr Infect Dis J. 2013 Apr;32(4):e163.

PMID:
18600190
[PubMed - indexed for MEDLINE]
10.

Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.

Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, Douha M, Willems P.

Vaccine. 2009 May 5;27(20):2701-6. doi: 10.1016/j.vaccine.2009.02.044. Epub 2009 Feb 24.

PMID:
19428882
[PubMed - indexed for MEDLINE]
11.

The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.

Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ; Consistency Lot Study Group for ProQuad.

Pediatr Infect Dis J. 2006 Jul;25(7):615-22.

PMID:
16804432
[PubMed - indexed for MEDLINE]
12.

Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.

Goh P, Lim FS, Han HH, Willems P.

Infection. 2007 Oct;35(5):326-33. Epub 2007 Aug 20.

PMID:
17710370
[PubMed - indexed for MEDLINE]
13.

Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.

Nolan T, McIntyre P, Roberton D, Descamps D.

Vaccine. 2002 Dec 13;21(3-4):281-9.

PMID:
12450703
[PubMed - indexed for MEDLINE]
14.

Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.

Klein NP, Fireman B, Yih WK, Lewis E, Kulldorff M, Ray P, Baxter R, Hambidge S, Nordin J, Naleway A, Belongia EA, Lieu T, Baggs J, Weintraub E; Vaccine Safety Datalink.

Pediatrics. 2010 Jul;126(1):e1-8. doi: 10.1542/peds.2010-0665. Epub 2010 Jun 29.

PMID:
20587679
[PubMed - indexed for MEDLINE]
Free Article
15.

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.

Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, DeStefano F, Chen RT, Immanuel V, Pearson JA, Vadheim CM, Rebolledo V, Christakis D, Benson PJ, Lewis N; Centers for Disease Control and Prevention Vaccine Safety Datalink Working Group.

N Engl J Med. 2001 Aug 30;345(9):656-61.

PMID:
11547719
[PubMed - indexed for MEDLINE]
Free Article
16.

Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.

MacDonald SE, Dover DC, Simmonds KA, Svenson LW.

CMAJ. 2014 Jun 9. pii: cmaj.140078. [Epub ahead of print]

PMID:
24914115
[PubMed - as supplied by publisher]
17.

Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of combination MMRV vaccine.

Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices (ACIP).

MMWR Morb Mortal Wkly Rep. 2008 Mar 14;57(10):258-60.

PMID:
18340332
[PubMed - indexed for MEDLINE]
Free Article
18.

Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial.

Prymula R, Bergsaker MR, Esposito S, Gothefors L, Man S, Snegova N, Stefkovičova M, Usonis V, Wysocki J, Douha M, Vassilev V, Nicholson O, Innis BL, Willems P.

Lancet. 2014 Apr 12;383(9925):1313-24. doi: 10.1016/S0140-6736(12)61461-5. Epub 2014 Jan 29.

PMID:
24485548
[PubMed - indexed for MEDLINE]
19.

Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in children.

Rowhani-Rahbar A, Fireman B, Lewis E, Nordin J, Naleway A, Jacobsen SJ, Jackson LA, Tse A, Belongia EA, Hambidge SJ, Weintraub E, Baxter R, Klein NP.

JAMA Pediatr. 2013 Dec;167(12):1111-7. doi: 10.1001/jamapediatrics.2013.2745.

PMID:
24126936
[PubMed - indexed for MEDLINE]
20.

Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra).

Dhillon S, Curran MP.

Paediatr Drugs. 2008;10(5):337-47. Review.

PMID:
18754700
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk